MPS5304 Regulatory science and monitoring medicine use
Faculty of Pharmacy and Pharmaceutical Sciences
MPS5304 Regulatory science and monitoring medicine use is a level 5, 6-credit-point, postgraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2026 in Semester 1 at Malaysia and Parkville. It has no prerequisites.
- Credit points
- 6
- Offered in 2026
- Semester 1
- Malaysia, Parkville
- Assessment
- No exam
- 5 tasks
This is the 2026 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review MPS5304.
Requisites
Before MPS5304
No prerequisites or corequisites besides the enrolment rules below.
After MPS5304
No unit lists MPS5304 as a prerequisite in the 2026 handbook.
Enrolment rules
Prerequisite: one of MPS5201, MPS5202, MPS5203 or MPS5204
Overview
This unit guides you through the paradigm in which approved medicines are monitored and regulated in their wider clinical use. In the unit, you will build a foundation understanding of pharmacoepidemiology, pharmacoeconomics, and the safe use of medicines through the lens of evidence-based practice. You will explore the frameworks used to evaluate medicine use and cost-effectiveness to inform policy and funding decisions, as well as drive clinical decision making. Upon completing this unit, you will have a comprehensive view of the issues surrounding the effective use of medicines in the broader population, and how to address these global issues from a practical perspective.
Offerings in 2026
| Teaching period | Campus | Mode |
|---|---|---|
| First semester | Malaysia | On campus |
| First semester | Parkville | On campus |
Assessment
- Workshop assessmentExercise20%
- Critical appraisal of a piece of research evidenceWritten20%
- Evidence SynthesisWritten20%
- Evaluation of cost-effectivenessWritten20%
- Oral PresentationPresentationCompetency hurdle20%
Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.
Learning outcomes
When you finish this unit, you should be able to:
- 1
Critically appraise and apply research evidence as the basis for clinical and regulatory decision making
- 2
Critically examine and report on the pharmacoepidemiology of medicines in a contemporary context
- 3
Examine and critically apply the principles of health economics and pharmacoeconomics in the drug evaluation lifecycle
- 4
Critically evaluate different sources of evidence including clinical practice guidelines, systematic reviews and meta-analyses regarding the benefits and risks of medicine treatment
- 5
Synthesise and critically examine the complex interplay of comparative effectiveness with the economic, legal, ethical, social and sustainability aspects in drug development and use
- 6
Demonstrate effective oral and written communication skills to communicate findings regarding regulatory science and the monitoring of medicine use in the wider population.
Workload and teaching
- Assessments4 hours
- Applied sessions12 hours
- Workshops24 hours
- Teaching approachEnquiry-based learning
- Teaching approachRole play
- Teaching approachActive learning
- Teaching approachPeer assisted learning
- 24 hours of preparation for classes
- Twelve 1-hour applied classes
- Twelve 2-hour workshops
- 5 hours of assessments
- 54 hours of independent work
- 25 hours of group work
Learning resources
Technology resources
This unit requires access to a laptop that meets minimum specifications. Free specialist software is available via MoVE.
Contacts
- Unit Coordinators
- Dr Omotayo Oladuntoye Fatokun
- Associate Professor Lauren May
- Chief Examiners
- Associate Professor Lauren May
Common questions
What are the prerequisites for MPS5304?
MPS5304 has no prerequisites, but enrolment rules apply.
When is MPS5304 offered?
In 2026, MPS5304 runs in Semester 1 at Malaysia and Parkville.
Does MPS5304 have an exam?
No. MPS5304 has 5 assessment tasks and no exam.